Implantable medical device with chemical sensor and related methods
In an embodiment, the invention includes an implantable medical device with a pulse generator and a chemical sensor in communication with the pulse generator, the chemical sensor configured to detect an ion concentration in a bodily fluid. In an embodiment, the invention includes a method for providing cardiac arrhythmia therapy to a patient including sensing a physiological concentration of an analyte, communicating data regarding the physiological concentration of the analyte to an implanted pulse generator, and delivering therapy to the patient based in part on the physiological concentration of the ion. In an embodiment, the invention includes a method for monitoring diuretic therapy. In an embodiment, the invention includes a method for controlling delivery of an active agent into a human body. Other aspects and embodiments are provided herein.
1. A method for providing cardiac arrhythmia therapy to a patient comprising:
optically measuring a physiological concentration of an ion in a bodily fluid of the patient with chronically implanted chemical sensor, the chemical sensor comprising
a sensing element comprising a potassium ion selective complexing moiety, the potassium ion selective complexing moiety selected from the group comprising cryptands, crown ethers, bis-crown ethers, calixarenes, noncyclic amides, and hemispherands;
an excitation assembly configured to illuminate the sensing element;
a detection assembly configured to receive light from the sensing element;
an opaque cover layer disposed over a side of the sensing element; and
a battery in communication with the excitation assembly, wherein all components of the chemical sensor are implanted within the patient;
transmitting data regarding the physiological concentration of the ion to an implanted pulse generator;
measuring temperature with an implanted temperature sensor;
calculating a compensated physiological concentration measurement of the ion using the measured temperature and the transmitted data regarding the physiological concentration of the ion;
storing the compensated physiological concentration measurement of the ion with an associated time stamp in a memory of the implanted pulse generator; and
delivering cardiac arrhythmia therapy from the implanted pulse generator to the patient based in part on the compensated physiological concentration of the ion.
2. The method of claim 1 , further comprising optically sensing a physiological concentration of a non-ionic component of the bodily fluid.
3. The method of claim 1 , wherein transmitting data regarding the physiological concentration of the ion to an implanted pulse generator comprises wirelessly transmitting data to the implanted pulse generator.
4. The method of claim 1 , further comprising reporting the data regarding the physiological concentration of the ion to a non-implanted device via a telemetry link.
5. The method of claim 1 , further comprising reporting the data regarding the physiological concentration of the ion to a medical professional via a telemetry link.
6. The method of claim 1 , further comprising combining the data regarding the physiological concentration of the ion with data regarding the patient's cardio-respiratory system to form a composite profile of the patient's cardiac condition.
7. The method of claim 6 , further comprising reporting the composite profile of the patient's cardiac health to a non-implanted device via a telemetry link.
8. The method of claim 6 , the data regarding the patient's cardio-respiratory system selected from the group consisting of an EKG signal, respiration rate, accelerometer data, trans-thoracic impedance, lead impedance, cardiac volume, blood pressure, weight, and cardiac necrosis signals.
9. A method for controlling delivery of an active agent into a human body, the method comprising:
measuring a physiological concentration of one or more analytes with chronically implanted system comprising a pulse generator and a chemical sensor, the chemical sensor comprising
a sensing element comprising a potassium ion selective complexing moiety, the potassium ion selective complexing moiety selected from the group comprising cryptands, crown ethers, bis-crown ethers, calixarenes, noncyclic amides, and hemispherands;
an excitation assembly configured to illuminate the sensing element;
a detection assembly configured to receive light from the sensing element;
an opaque cover layer disposed over a side of the sensing element; and
a battery in communication with the excitation assembly, wherein all components of the chemical sensor are implanted within the patient;
measuring temperature with an implanted temperature sensor;
calculating a compensated physiological concentration measurement of the one or more analytes using the measured temperature and data from the detection assembly;
storing the compensated physiological concentration measurement of the ion with an associated time stamp in a memory of the chronically implanted system; and
varying delivery of the substance at least in part as a function of the compensated physiological concentration of the one or more analytes.
10. The method of claim 9 , the active agent comprising a diuretic.
11. The method of claim 9 , in which measuring a physiological concentration comprises measuring a concentration in a bodily fluid selected from the group consisting of blood, interstitial fluid, serum, lymph, and serous fluid.